Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers
Titel:
Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers
Auteur:
Wheler, Jennifer J. Janku, Filip Falchook, Gerald S. Jackson, Tiffiny L. Fu, Siqing Naing, Aung Tsimberidou, Apostalia M. Moulder, Stacy L. Hong, David S. Yang, Hui Piha-Paul, Sarina A. Atkins, Johnique T. Garcia-Manero, Guillermo Kurzrock, Razelle